Thiolated Chitosan Microneedle Patch of Levosulpiride from Fabrication, Characterization to Bioavailability Enhancement Approach

Abstract

In this study, a first attempt has been made to deliver levosulpiride transdermally through a thiolated chitosan microneedle patch (TC-MNP). Levosulpiride is slowly and weakly absorbed from the gastrointestinal tract with an oral bioavailability of less than 25% and short half-life of about 6 h. In order to enhance its bioavailability, levosulpiride-loaded thiolated chitosan microneedle patches (LS-TC-MNPs) were fabricated. Firstly, thiolated chitosan was synthesized and characterized by nuclear magnetic resonance (1HNMR) spectroscopy, attenuated total reflectance-Fourier transform infrared (ATR-FTIR) spectroscopy, differential scanning calorimetry (DSC), and X-ray diffraction (XRD). Thiolated chitosan has been used in different drug delivery systems; herein, thiolated chitosan has been used for the transdermal delivery of LS. LS-TC-MNPs were fabricated from different concentrations of thiolated chitosan solution. Furthermore, the levosulpiride-loaded thiolated chitosan microneedle patch (LS-TC-MNP) was characterized by FTIR spectroscopic analysis, scanning electron microscopy (SEM) study, penetration ability, tensile strength, moisture content, patch thickness, and elongation test. LS-TC-MNP fabricated with 3% thiolated chitosan solution was found to have the best tensile strength, moisture content, patch thickness, elongation, drug-loading efficiency, and drug content. Thiolated chitosan is biodegradable, nontoxic and has good absorption and swelling in the skin. LS-TC-MNP-3 consists of 100 needles in 10 rows each with 10 needles. The length of each microneedle was 575 μm; they were pyramidal in shape, with sharp pointed ends and a base diameter of 200 µm. The microneedle patch (LS-TC-MNP-3) resulted in-vitro drug release of 65% up to 48 h, ex vivo permeation of 63.6%, with good skin biocompatibility and enhanced in-vivo pharmacokinetics (AUC = 986 µg/mL·h, Cmax = 24.5 µg/mL) as compared to oral LS dispersion (AUC = 3.2 µg/mL·h, Cmax = 0.5 µg/mL). Based on the above results, LS-TC-MNP-3 seems to be a promising strategy for enhancing the bioavailability of levosulpiride.

Identification of Key Genes in Nasopharyngeal Carcinoma Based on Bioinformatics Analysis

“…MUC1 expression is reported to be an important molecular marker of cervical squamous cell carcinoma [ 16 ]. Numerous studies confirmed that MUC1 can enhance the proliferation and metastasis of different tumor cells [ 17 – 19 ]. The cytoplasmic end of MUC1 can be used as a scaffold to activate multiple signal pathways through the activation of specific kinases, including PI3K, Akt, and MAPK [ 20 – 22 ].…”

Application Effect of Somatostatin Combined with Transnasal Ileus Catheterization in Patients with Acute Intestinal Obstruction and Advanced Gastric Cancer

“…After surgery, due to the decrease of gastrointestinal motion amplitude and degree, an internal hernia or intestinal loop is generated between the intestines, which eventually leads to acute intestinal obstruction [ 13 ]. Clinical treatment of intestinal obstruction is mostly symptomatic treatment and surgical treatment, among which surgical treatment is more stimulating and damaging to the body and prone to postoperative adverse events [ 14 ]. Therefore, the selection of safe and effective treatment means is the focus of the gastroenterology department.…”

Formulation Development and Investigations on Therapeutic Potential of Nanogel from Beta vulgaris L. Extract in Testosterone‐Induced Alopecia

“…The Higuchi plot is known as a curve drawn between square root of time taken on X axis and cumulative drug release on Y axis. In the Korsmeyer-Peppas plot, a curve was drawn between log time taken on X axis and log percentage cumulative drug release on Y axis [ 40 , 41 ].…”